{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:21:42Z","timestamp":1759882902823,"version":"build-2065373602"},"reference-count":46,"publisher":"Akademiai Kiado Zrt.","issue":"3","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["EuJMI"],"published-print":{"date-parts":[[2025,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Ceftriaxone-induced biliary pseudolithiasis is a disease entity frequently observed in children, while it is rarely seen in adult patients. We provide a thorough sonographic workup of the case to guide sonographers confronted with it.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>A 41-years-old male patient with sonographically confirmed, culture-negative endocarditis accompanied by repeated fever episodes received 4g ceftriaxone per day next to ampicillin and gentamicin as an element of his antibiotic therapy. At day 4 of treatment, signs of gall bladder sludge and biliary pseudolithiasis were first seen in sonography. At day 17, abdominal pain over 30\u2009min and increased liver and pancreatic enzymes pointed towards temporal duct obstruction as a complication and ceftriaxone therapy had to be preterm cancelled. A sonographic work-up of the stepwise improvement of the sonographic findings after the end of the ceftriaxone therapy is provided, a reemergence of endocarditis was not observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The case reminds of a rarely recognized, usually reversible side effect of high-dose ceftriaxone therapy and its complications. The sonographic work-up may serve as guidance for clinicians during follow-up assessments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although ceftriaxone allows usually well-tolerated antimicrobial therapies, biliary pseudolithiasis should be kept in mind as a rare but sometimes non-ignorable side effect.<\/jats:p><\/jats:sec>","DOI":"10.1556\/1886.2025.00041","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T12:35:40Z","timestamp":1755606940000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":1,"title":["Gall bladder sludge and biliary pseudolithiasis as rare complications of ceftriaxone therapy in adult patients \u2013 A case report including sonographic workup"],"prefix":"10.1556","volume":"15","author":[{"given":"Sven","family":"Jungblut","sequence":"first","affiliation":[{"name":"Practice Dr. Sven Jungblut, Frankfurt\/Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Aland","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics and Computer Science, TU Bergakademie Freiberg, Freiberg, Germany"},{"name":"Faculty of Informatics\/Mathematics, HTW Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens-Uwe","family":"Erk","sequence":"additional","affiliation":[{"name":"Diakonissen-Hospital Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Aland","sequence":"additional","affiliation":[{"name":"Diakonissen-Hospital Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8967-9528","authenticated-orcid":true,"given":"Hagen","family":"Frickmann","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, Hamburg, Germany"},{"name":"Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock, Rostock, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"B1","series-title":"BMJ Open","article-title":"Safety of ceftriaxone in paediatrics: a systematic review protocol","volume":"7","author":"Zeng L","year":"2017","unstructured":"Zeng L, Choonara I, Zhang L, Xue S, Chen Z, He M. Safety of ceftriaxone in paediatrics: a systematic review protocol. BMJ Open. 2017;7:e016273."},{"key":"B2","series-title":"Arch Dis Child","first-page":"981","article-title":"Safety of ceftriaxone in paediatrics: a systematic review","volume":"105","author":"Zeng L","year":"2020","unstructured":"Zeng L, Wang C, Jiang M, Chen K, Zhong H, Chen Z, et\u00a0al. Safety of ceftriaxone in paediatrics: a systematic review. Arch Dis Child. 2020;105:981\u20135."},{"key":"B3","series-title":"Am J Med","first-page":"38S","article-title":"Safety of parenteral third-generation cephalosporins","volume":"88","author":"Fekety FR","year":"1990","unstructured":"Fekety FR. Safety of parenteral third-generation cephalosporins. Am J Med. 1990;88:38S\u201344S."},{"key":"B4","series-title":"Oxf Med Case Rep","article-title":"Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review","volume":"2024","author":"Smerat MI","year":"2024","unstructured":"Smerat MI, Shawer B, AbuIrayyeh BM, Natsheh ST, Diab L, Shahin FB, et\u00a0al. Ceftriaxone-induced symptomatic cholelithiasis in a child: case report and literature review. Oxf Med Case Rep. 2024;2024:omae062."},{"key":"B5","series-title":"J Med Ultrason","first-page":"125","article-title":"A symptomatic child with ceftriaxone-associated biliary pseudolithiasis","volume":"35","author":"Kutuya N","year":"2001","unstructured":"Kutuya N, Ozaki Y, Okazaki T. A symptomatic child with ceftriaxone-associated biliary pseudolithiasis. J Med Ultrason (2001). 2008;35:125\u20138."},{"key":"B6","series-title":"Dev Period Med","first-page":"182","article-title":"Ceftriaxone-associated acute gallbladder enlargement \u2013 an unexpected diagnosis in the child with urinary tract infection","volume":"19","author":"Krzemie\u0144 G","year":"2015","unstructured":"Krzemie\u0144 G, Ksi\u0105\u017cczyk T, Szmigielska A, Bombi\u0144ski P, Roszkowska-Blaim M, Werner B, et\u00a0al. Ceftriaxone-associated acute gallbladder enlargement \u2013 an unexpected diagnosis in the child with urinary tract infection. Dev Period Med. 2015;19:182\u20135."},{"key":"B7","series-title":"Pediatr Med Chir","first-page":"369","article-title":"Pseudolithiasis caused by ceftriaxone in children: a case report","volume":"17","author":"Benedetti M","year":"1995","unstructured":"Benedetti M, Zanchetta S, Bagnani A, Praderio R, Perbellini S, Melo C. Pseudolithiasis caused by ceftriaxone in children: a case report. Pediatr Med Chir. 1995;17:369\u201371."},{"key":"B8","series-title":"Pediatr Int","first-page":"322","article-title":"Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study","volume":"46","author":"Bor O","year":"2004","unstructured":"Bor O, Dinleyici EC, Kebapci M, Aydogdu SD. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Pediatr Int. 2004;46:322\u20134."},{"key":"B9","series-title":"Pharmacotherapy","first-page":"1389","article-title":"Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature","volume":"25","author":"Bickford CL","year":"2005","unstructured":"Bickford CL, Spencer AP. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature. Pharmacotherapy. 2005;25:1389\u201395."},{"key":"B10","series-title":"Korean J Gastroenterol","first-page":"378","article-title":"Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult","volume":"63","author":"Jung HK","year":"2014","unstructured":"Jung HK, Lee DS. Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult. Korean J Gastroenterol. 2014;63:378\u201381."},{"key":"B11","series-title":"Nihon Shokakibyo Gakkai Zasshi","first-page":"569","article-title":"Acute pancreatitis associated with the administration of ceftriaxone in an adult patient","volume":"106","author":"Sasaki Y","year":"2009","unstructured":"Sasaki Y, Aoki S, Aoki K, Achiwa K, Yama T, Kubota M, et\u00a0al. Acute pancreatitis associated with the administration of ceftriaxone in an adult patient. Nihon Shokakibyo Gakkai Zasshi. 2009;106:569\u201375."},{"key":"B12","series-title":"J Glob Infect Dis","first-page":"31","article-title":"Rapid onset of ceftriaxone-induced cholelithiasis in an adult patient","volume":"14","author":"Abdelaziz H","year":"2022","unstructured":"Abdelaziz H, Cormier N, Levesque T, St-Yves J, Habash MA, Diaz O, et\u00a0al. Rapid onset of ceftriaxone-induced cholelithiasis in an adult patient. J Glob Infect Dis. 2022;14:31\u20134."},{"key":"B13","series-title":"J Korean Surg Soc","first-page":"423","article-title":"Gallbladder pseudolithiasis caused by ceftriaxone in young adult","volume":"81","author":"Choi YY","year":"2011","unstructured":"Choi YY, Jung YH, Choi SM, Lee CS, Kim D, Hur KY. Gallbladder pseudolithiasis caused by ceftriaxone in young adult. J Korean Surg Soc. 2011;81:423\u20136."},{"key":"B14","series-title":"Nihon Shokakibyo Gakkai Zasshi","first-page":"1481","article-title":"A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone","volume":"110","author":"Tomoda T","year":"2013","unstructured":"Tomoda T, Ueki T, Saito S, Tatsukawa M, Nawa T, Hamamoto H, et\u00a0al. A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone. Nihon Shokakibyo Gakkai Zasshi. 2013;110:1481\u20136."},{"key":"B15","series-title":"Drug Healthc Patient Saf","first-page":"103","article-title":"Ceftriaxone-associated nephrolithiasis and gallstone in adults","volume":"10","author":"Azarkar G","year":"2018","unstructured":"Azarkar G, Birjand MM, Ehsanbakhsh A, Bijari B, Abedini MR, Ziaee M. Ceftriaxone-associated nephrolithiasis and gallstone in adults. Drug Healthc Patient Saf. 2018;10:103\u2013108."},{"key":"B16","series-title":"Monatsschr Kinderheilkd","first-page":"488","article-title":"Epigastric colic after ceftriaxone therapy","volume":"140","author":"Sorantin E","year":"1992","unstructured":"Sorantin E, Fotter R, Hausegger KA, Grubbauer HM. Epigastric colic after ceftriaxone therapy. Monatsschr Kinderheilkd. 1992;140:488\u20139."},{"key":"B17","series-title":"Case Rep Med","article-title":"Usefulness of endoscopic managements in patients with ceftriaxone-induced pseudolithiasis causing biliary obstruction","volume":"2017","author":"Doi Y","year":"2017","unstructured":"Doi Y, Takii Y, Ito H, Jingu N, To K, Kimura S, et\u00a0al. Usefulness of endoscopic managements in patients with ceftriaxone-induced pseudolithiasis causing biliary obstruction. Case Rep Med. 2017;2017:3835825."},{"key":"B18","series-title":"Case Rep Med","article-title":"Acute cholecystitis caused by ceftriaxone stones in an adult","volume":"2009","author":"Becker CD","year":"2009","unstructured":"Becker CD, Fischer RA. Acute cholecystitis caused by ceftriaxone stones in an adult. Case Rep Med. 2009;2009:132452."},{"key":"B19","series-title":"Ann Ital Med Int","first-page":"202","article-title":"Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication","volume":"14","author":"Famularo G","year":"1999","unstructured":"Famularo G, Polchi S, De Simone C. Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication. Ann Ital Med Int. 1999;14:202\u20134."},{"key":"B20","series-title":"Surg Case Rep","first-page":"97","article-title":"Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case report","volume":"81","author":"Shigemori T","year":"2022","unstructured":"Shigemori T, Imoto I, Inoue Y, Nishiwaki R, Sugimasa N, Hamaguchi T, et\u00a0al. Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case report. Surg Case Rep. 2022;81:97."},{"key":"B21","series-title":"Gastroenterology","first-page":"1665","article-title":"Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate","volume":"100","author":"Park HZ","year":"1991","unstructured":"Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology. 1991;100:1665\u201370."},{"key":"B22","series-title":"J Gastroenterol Hepatol","first-page":"618","article-title":"Gall-bladder sludge: lessons from ceftriaxone","volume":"7","author":"Kim YS","year":"1992","unstructured":"Kim YS, Kestell MF, Lee SP. Gall-bladder sludge: lessons from ceftriaxone. J Gastroenterol Hepatol. 1992;7:618\u201321."},{"key":"B23","series-title":"Gastroenterology","first-page":"1769","article-title":"Ceftriaxone-associated gallbladder sludge: what's in a name?","volume":"100","author":"Palmer RH","year":"1991","unstructured":"Palmer RH. Ceftriaxone-associated gallbladder sludge: what's in a name? Gastroenterology. 1991;100:1769\u201372."},{"key":"B24","series-title":"Fundam Clin Pharmacol","first-page":"40","article-title":"Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?","volume":"35","author":"Cuzzolin L","year":"2021","unstructured":"Cuzzolin L, Oggiano AM, Clemente MG, Locci C, Antonucci L, Antonucci R. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Fundam Clin Pharmacol. 2021;35:40\u201352."},{"key":"B25","series-title":"Klin Padiatr","first-page":"421","article-title":"Ceftriaxone-induced cholelithiasis--a harmless side-effect?","volume":"205","author":"Riccabona M","year":"1993","unstructured":"Riccabona M, Kerbl R, Schwinger W, Spork D, Millner M, Grubbauer HM. Ceftriaxone-induced cholelithiasis--a harmless side-effect? Klin Padiatr. 1993;205:421\u20133."},{"key":"B26","series-title":"Pediatr Infect Dis J","first-page":"422","article-title":"Gallbladder sludge and antibiotics","volume":"9","author":"Lee SP","year":"1990","unstructured":"Lee SP, Lipsky BA, Teefey SA. Gallbladder sludge and antibiotics. Pediatr Infect Dis J. 1990;9:422\u20133."},{"key":"B27","series-title":"Drug Saf","first-page":"32","article-title":"Drug-induced gallbladder disease. Incidence, aetiology and management","volume":"7","author":"Michielsen PP","year":"1992","unstructured":"Michielsen PP, Fierens H, Van Maercke YM. Drug-induced gallbladder disease. Incidence, aetiology and management. Drug Saf. 1992;7:32\u201345."},{"key":"B28","series-title":"Ann Trop Paediatr","first-page":"25","article-title":"Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study","volume":"24","author":"Acun C","year":"2004","unstructured":"Acun C, Erdem LO, S\u00f6\u011f\u00fct A, Erdem CZ, Toma\u00e7 N, G\u00fcndo\u011fdu S, et\u00a0al. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study. Ann Trop Paediatr. 2004;24:25\u201331."},{"key":"B29","series-title":"Chemotherapy","first-page":"316","article-title":"Clinical experience with ceftriaxone treatment in the neonate","volume":"41","author":"Van Reempts PJ","year":"1995","unstructured":"Van Reempts PJ, Van Overmeire B, Mahieu LM, Vanacker KJ. Clinical experience with ceftriaxone treatment in the neonate. Chemotherapy. 1995;41:316\u201322."},{"key":"B30","series-title":"Gastroenterology","first-page":"1772","article-title":"Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility","volume":"99","author":"Shiffman ML","year":"1990","unstructured":"Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology. 1990;99:1772\u20138."},{"key":"B31","series-title":"Zhonghua Er Ke Za Zhi","first-page":"216","article-title":"Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases","volume":"48","author":"Zhong XH","year":"2010","unstructured":"Zhong XH, Chen H, Yao Y, Zhuo XW, Huang JP, Xiao HJ, et\u00a0al. Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases. Zhonghua Er Ke Za Zhi. 2010;48:216\u20139."},{"key":"B32","series-title":"Ther Apher Dial","first-page":"393","article-title":"Hemodialysis as a risk factor for ceftriaxone-associated pseudolithiasis in adults","volume":"24","author":"Ubukata M","year":"2020","unstructured":"Ubukata M, Ohsawa I, Suzuki H, Asao R, Nakamura Y, Nishida H, et\u00a0al. Hemodialysis as a risk factor for ceftriaxone-associated pseudolithiasis in adults. Ther Apher Dial. 2020;24:393\u20139."},{"key":"B33","series-title":"Pediatr Int","first-page":"942","article-title":"Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis","volume":"57","author":"Murata S","year":"2015","unstructured":"Murata S, Aomatsu T, Yoden A, Tamai H. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis. Pediatr Int. 2015;57:942\u20136."},{"key":"B34","series-title":"Acta Radiol","first-page":"112","article-title":"Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children","volume":"46","author":"Ozturk A","year":"2005","unstructured":"Ozturk A, Kaya M, Zeyrek D, Ozturk E, Kat N, Ziylan SZ. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children. Acta Radiol. 2005;46:112\u20136."},{"key":"B35","series-title":"Hum Exp Toxicol","first-page":"547","article-title":"Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: a prospective study in 154 children","volume":"36","author":"Ustyol L","year":"2017","unstructured":"Ustyol L, Bulut MD, Agengin K, Bala KA, Yavuz A, Bora A, et\u00a0al. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: a prospective study in 154 children. Hum Exp Toxicol. 2017;36:547\u201353."},{"key":"B36","series-title":"J\u00a0Clin Ultrasound","first-page":"217","article-title":"Ceftriaxone-associated biliary pseudolithiasis in children","volume":"34","author":"Biner B","year":"2006","unstructured":"Biner B, Oner N, Celtik C, Bostancio\u011flu M, Tun\u00e7bilek N, G\u00fczel A, et\u00a0al. Ceftriaxone-associated biliary pseudolithiasis in children. J\u00a0Clin Ultrasound. 2006;34:217\u201322."},{"key":"B37","series-title":"J Clin Ultrasound","first-page":"166","article-title":"Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children","volume":"28","author":"Palanduz A","year":"2000","unstructured":"Palanduz A, Yal\u00e7in I, Tongu\u00e7 E, G\u00fcler N, One\u015f U, Salman N, et\u00a0al. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound. 2000;28:166\u20138."},{"issue":"163\u20135","key":"B38","series-title":"Harefuah","first-page":"215","article-title":"Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone","volume":"127","author":"Barzilai M.","year":"1994","unstructured":"Barzilai M. Sonographic demonstration of pseudo-cholelithiasis after ceftriaxone. Harefuah. 1994;127:163\u20135, 215."},{"key":"B39","series-title":"Jpn J Radiol","first-page":"826","article-title":"Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults","volume":"37","author":"Yoshida R","year":"2019","unstructured":"Yoshida R, Yoshizako T, Katsube T, Kitagaki H. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults. Jpn J Radiol. 2019;37:826\u201331."},{"key":"B40","series-title":"J\u00a0Cardiovasc Med (Hagerstown)","first-page":"718","article-title":"The 2023 new European guidelines on infective endocarditis: main novelties and implications for clinical practice","volume":"25","author":"Imazio M","year":"2024","unstructured":"Imazio M. The 2023 new European guidelines on infective endocarditis: main novelties and implications for clinical practice. J\u00a0Cardiovasc Med (Hagerstown). 2024;25:718\u201326."},{"key":"B41","series-title":"J\u00a0Thorac Cardiovasc Surg","first-page":"e183","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"162","author":"Writing Committee Members","year":"2021","unstructured":"Writing Committee Members, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, et\u00a0al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. J\u00a0Thorac Cardiovasc Surg. 2021;162:e183\u2013353."},{"key":"B42","series-title":"Ann Transl Med","first-page":"1625","article-title":"Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association\/American College of Cardiology and European Society of Cardiology guidelines","volume":"8","author":"Satriano UM","year":"2020","unstructured":"Satriano UM, Nenna A, Spadaccio C, Pollari F, Fischlein T, Chello M, et\u00a0al. Guidelines on prosthetic heart valve management in infective endocarditis: a narrative review comparing American Heart Association\/American College of Cardiology and European Society of Cardiology guidelines. Ann Transl Med. 2020;8:1625."},{"key":"B43","series-title":"Interact Cardiovasc Thorac Surg","first-page":"678","article-title":"Fluorescence in situ hybridization for identification and visualization of microorganisms in infected heart valve tissue as addition to standard diagnostic tests improves diagnosis of endocarditis","volume":"29","author":"Eichinger S","year":"2019","unstructured":"Eichinger S, Kikhney J, Moter A, Wie\u00dfner A, Eichinger WB. Fluorescence in situ hybridization for identification and visualization of microorganisms in infected heart valve tissue as addition to standard diagnostic tests improves diagnosis of endocarditis. Interact Cardiovasc Thorac Surg. 2019;29:678\u201384."},{"key":"B44","series-title":"Clin Infect Dis","first-page":"1050","article-title":"New perspectives for prosthetic valve endocarditis: impact of molecular imaging by FISHseq diagnostics","volume":"76","author":"Hajduczenia MM","year":"2023","unstructured":"Hajduczenia MM, Klefisch FR, Hopf AGM, Grubitzsch H, Stegemann MS, Pf\u00e4fflin F, et\u00a0al. New perspectives for prosthetic valve endocarditis: impact of molecular imaging by FISHseq diagnostics. Clin Infect Dis. 2023;76:1050\u20138."},{"key":"B45","series-title":"Eur Heart J","first-page":"3948","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"Delgado V","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et\u00a0al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023;44:3948\u20134042."},{"key":"B46","series-title":"Clin Microbiol Infect","first-page":"723","article-title":"Aminoglycosides for infective endocarditis: time to say goodbye?","volume":"26","author":"Lebeaux D","year":"2020","unstructured":"Lebeaux D, Fern\u00e1ndez-Hidalgo N, Pilmis B, Tattevin P, Mainardi JL. Aminoglycosides for infective endocarditis: time to say goodbye? Clin Microbiol Infect. 2020;26:723\u20138."}],"container-title":["European Journal of Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/1886\/15\/3\/article-p150.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/1886\/15\/3\/article-p150.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/1886\/15\/3\/article-p150.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:07:16Z","timestamp":1759842436000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/1886\/15\/3\/article-p150.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":46,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1556\/1886.2025.00041","relation":{},"ISSN":["2062-509X","2062-8633"],"issn-type":[{"type":"print","value":"2062-509X"},{"type":"electronic","value":"2062-8633"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}